tetano
Editor, Senior Moderator
BMC Infect Dis. 2017 Jul 3;17(1):464. doi: 10.1186/s12879-017-2564-9.
[h=1]Cost-effectiveness analysis of N95 respirators and medical masks to protect healthcare workers in China from respiratory infections.[/h] Mukerji S[SUP]1[/SUP], MacIntyre CR[SUP]2,[/SUP][SUP]3[/SUP], Seale H[SUP]2[/SUP], Wang Q[SUP]4[/SUP], Yang P[SUP]4[/SUP], Wang X[SUP]4[/SUP], Newall AT[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] There are substantial differences between the costs of medical masks and N95 respirators. Cost-effectiveness analysis is required to assist decision-makers evaluating alternative healthcare worker (HCW) mask/respirator strategies. This study aims to compare the cost-effectiveness of N95 respirators and medical masks for protecting HCWs in Beijing, China.
[h=4]METHODS:[/h] We developed a cost-effectiveness analysis model utilising efficacy and resource use data from two cluster randomised clinical trials assessing various mask/respirator strategies conducted in HCWs in Level 2 and 3 Beijing hospitals for the 2008-09 and 2009-10 influenza seasons. The main outcome measure was the incremental cost-effectiveness ratio (ICER) per clinical respiratory illness (CRI) case prevented. We used a societal perspective which included intervention costs, the healthcare costs of CRI in HCWs and absenteeism costs.
[h=4]RESULTS:[/h] The incremental cost to prevent a CRI case with continuous use of N95 respirators when compared to medical masks ranged from US $490-$1230 (approx. 3000-7600 RMB). One-way sensitivity analysis indicated that the CRI attack rate and intervention effectiveness had the greatest impact on cost-effectiveness.
[h=4]CONCLUSIONS:[/h] The determination of cost-effectiveness for mask/respirator strategies will depend on the willingness to pay to prevent a CRI case in a HCW, which will vary between countries. In the case of a highly pathogenic pandemic, respirator use in HCWs would likely be a cost-effective intervention.
[h=4]KEYWORDS:[/h] Cost-effectiveness; Economic evaluation; Healthcare worker; Mask; N95 respirator
PMID: 28673259 DOI: 10.1186/s12879-017-2564-9
Free PMC Article
[h=1]Cost-effectiveness analysis of N95 respirators and medical masks to protect healthcare workers in China from respiratory infections.[/h] Mukerji S[SUP]1[/SUP], MacIntyre CR[SUP]2,[/SUP][SUP]3[/SUP], Seale H[SUP]2[/SUP], Wang Q[SUP]4[/SUP], Yang P[SUP]4[/SUP], Wang X[SUP]4[/SUP], Newall AT[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] There are substantial differences between the costs of medical masks and N95 respirators. Cost-effectiveness analysis is required to assist decision-makers evaluating alternative healthcare worker (HCW) mask/respirator strategies. This study aims to compare the cost-effectiveness of N95 respirators and medical masks for protecting HCWs in Beijing, China.
[h=4]METHODS:[/h] We developed a cost-effectiveness analysis model utilising efficacy and resource use data from two cluster randomised clinical trials assessing various mask/respirator strategies conducted in HCWs in Level 2 and 3 Beijing hospitals for the 2008-09 and 2009-10 influenza seasons. The main outcome measure was the incremental cost-effectiveness ratio (ICER) per clinical respiratory illness (CRI) case prevented. We used a societal perspective which included intervention costs, the healthcare costs of CRI in HCWs and absenteeism costs.
[h=4]RESULTS:[/h] The incremental cost to prevent a CRI case with continuous use of N95 respirators when compared to medical masks ranged from US $490-$1230 (approx. 3000-7600 RMB). One-way sensitivity analysis indicated that the CRI attack rate and intervention effectiveness had the greatest impact on cost-effectiveness.
[h=4]CONCLUSIONS:[/h] The determination of cost-effectiveness for mask/respirator strategies will depend on the willingness to pay to prevent a CRI case in a HCW, which will vary between countries. In the case of a highly pathogenic pandemic, respirator use in HCWs would likely be a cost-effective intervention.
[h=4]KEYWORDS:[/h] Cost-effectiveness; Economic evaluation; Healthcare worker; Mask; N95 respirator
PMID: 28673259 DOI: 10.1186/s12879-017-2564-9
Free PMC Article